Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials

Por Manton, Kerry J, Gauld, Cassandra S, White, Katherine M, Griffin, Paul M, Elliott, Suzanne L
Publicado no BMJ Open (2019)

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimm...

Por Misko, Ihor S., Cross, Simone M., Khanna, Rajiv, Elliott, Suzanne L., Schmidt, Christopher, Pye, Stephanie J., Silins, Sharon L.
Publicado em 1999

Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

Por Khanna, Rajiv, Bell, Scott, Sherritt, Martina, Galbraith, Andrew, Burrows, Scott R., Rafter, Lee, Clarke, Belinda, Slaughter, Richard, Falk, Michael C., Douglass, Jo, Williams, Trevor, Elliott, Suzanne L., Moss, Denis J.
Publicado em 1999

Phase I Trial of a CD8(+) T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

Por Elliott, Suzanne L., Suhrbier, Andreas, Miles, John J., Lawrence, Greg, Pye, Stephanie J., Le, Thuy T., Rosenstengel, Andrew, Nguyen, Tam, Allworth, Anthony, Burrows, Scott R., Cox, John, Pye, David, Moss, Denis J., Bharadwaj, Mandvi
Publicado em 2008

Phase 1 Safety and Immunogenicity Trial of the Plasmodium falciparum Blood-Stage Malaria Vaccine AMA1-C1/ISA 720 in Australian Adults

Por Pierce, Mark A., Ellis, Ruth D., Martin, Laura B., Malkin, Elissa, Tierney, Eveline, Miura, Kazutoyo, Fay, Michael P., Marjason, Joanne, Elliott, Suzanne L., Mullen, Gregory E. D., Rausch, Kelly, Zhu, Daming, Long, Carole A., Miller, Louis H.
Publicado em 2010